| Schwabe Pharma AG - Prostaplant-F, Weichkapseln | | 66329 | | 01 | | Prostaplant-F | | Weichkapseln | | G04CX02 | | Serenoa repens | | 21.12.2016 | | |
| | Composition | | Sabalis serrulatae extractum (Serenoa repens (W.Bartram) Small, fructus) 160 mg DER: 10-14.3:1 Auszugsmittel ethanolum 93% (V/V), urticae radicis extractum ethanolicum siccum (Urtica urens L., Urtica dioica L., radix) 120 mg DER: 7.6-12.5:1 Auszugsmittel ethanolum 68% (V/V), silica colloidalis anhydrica, sojae oleum hydrogenatum 10-63.6 mg, adeps solidus, Kapselhülle: succinogelatina, glycerolum (85 per centum), E 131, E 172 (flavum), E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Sabal Extractum Ethanolicum Spissum | 160 mg | | Urticae Radicis Extractum Ethanolicum Siccum | 120 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Sabal Extractum Ethanolicum Spissum | 160 mg | | Urticae Radicis Extractum Ethanolicum Siccum | 120 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Auszugsmittel Ethanolum 60 % (M/m) | | | | Auszugsmittel Ethanolum 90 % (M/m) | | | | Der: 10-14.3:1 | | | | Der: 7.6-12.5:1 | | | | E 131 | | color. |
| |
| |
|
